The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,065.00
Bid: 1,020.00
Ask: 1,100.00
Change: 0.00 (0.00%)
Spread: 80.00 (7.843%)
Open: 1,065.00
High: 0.00
Low: 0.00
Prev. Close: 1,065.00
ARBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Arbuthnot Securities Limited

18 Nov 2011 07:00

RNS Number : 3379S
Arbuthnot Banking Group PLC
18 November 2011
 



 

 

For Immediate Release

 

PRESS RELEASE 18 November 2011

 

 

 

 ARBUTHNOT BANKING GROUP PLC

 

 

ANNOUNCEMENT RE ARBUTHNOT SECURITIES LIMITED

 

 

 

Further to the announcement made by Arbuthnot Banking Group PLC ("Arbuthnot" or "the Group") on 9 November 2011 regarding Arbuthnot Securities Limited ("Arbuthnot Securities"), Arbuthnot today announces that it has entered into a conditional contract to sell its investment banking division, Arbuthnot Securities, to Westhouse Holdings PLC ("Westhouse"). The sale remains subject to regulatory approval.

 

In the year to 31 December 2010 Arbuthnot Securities made a profit before tax of £1.0m and for the six months to 30 June 2011 it reported a pre-tax loss of £3.4m. Westhouse has agreed to buy Arbuthnot Securities together with its outstanding subordinated loan of £1.5m for a total of £1.9m. It has also been agreed that, when utilised, Arbuthnot will receive 75 per cent. of a £1.9m deferred tax asset which Westhouse will acquire with the business. The total consideration including the deferred tax asset represents a £1.2m discount to the aggregate of the £3.0m of the approximate unaudited net assets of Arbuthnot Securities as at 31 October 2011 and the £1.5m subordinated loan.

 

The balance sheet effect of the transaction for Arbuthnot will be a reduction in net assets of £4.4m. This will include the cost of closing a Long Term Incentive Plan ("LTIP") set up for employees of Arbuthnot Securities and does not include any benefit from deferred consideration resulting from the deferred tax asset. Arbuthnot's regulatory capital requirement is expected to be reduced by approximately £3.3m as it will no longer need to hold capital for an investment banking business.

 

The upfront consideration payable by Westhouse will consist of £1.0m in cash, 1.25m Westhouse shares (resulting in Arbuthnot owning 9.37% of the enlarged share capital) and £350,000 of convertible loan notes. Arbuthnot has agreed to retain its shareholding in Westhouse for a minimum of 12 months.

 

 

 

Enquiries:

 

Arbuthnot Banking Group PLC Tel: 020 7012 2400

Henry Angest, Chairman and Chief Executive

Andrew Salmon, Chief Operating Officer

James Cobb, Group Finance Director

David Marshall, Director of Communications

 

Hawkpoint Partners Limited (Nominated Adviser) Tel: 020 7665 4500

Lawrence Guthrie

 

Numis Securities Limited Tel: 020 7260 1000

Christopher Wilkinson

Mark Lander

 

Pelham Bell Pottinger Tel: 020 7861 3232

Ben Woodford

Dan de Belder

 

 

 

Hawkpoint Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as nominated adviser to Arbuthnot Banking Group PLC and is acting for no-one else in connection with the sale of Arbuthnot Securities Limited and will not be responsible to anyone other than Arbuthnot Banking Group PLC providing the protections afforded to clients of Hawkpoint Partners Limited nor for providing advice in connection with the sale of Arbuthnot Securities Limited or any other matter referred to herein.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLDLLFFFFFFBF
Date   Source Headline
22nd Apr 20243:49 pmEQSQ&A on Arbuthnot Banking Group (ARBB) | 2023 results, strategic choices paying dividends
8th Apr 20243:50 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB): 2023 - delivering strategy with strong profit growth
28th Mar 20247:00 amRNSAudited Final Results
21st Feb 20247:00 amRNSPre Close Trading Update
8th Feb 20241:57 pmRNSDirector/PDMR Shareholding
19th Dec 20232:06 pmRNSRenewal of Tier 2 Regulatory Capital Loan facility
5th Dec 202312:47 pmRNSDirector/PDMR Shareholding
13th Nov 20233:40 pmEQSHardman & Co Q&A on Arbuthnot Banking Group: Strategic progress and investments towards ‘Future State 2’
30th Oct 202310:34 amRNSDirector/PDMR Shareholding
26th Oct 202310:05 amRNSDirector/PDMR Shareholding
24th Oct 20233:15 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) Trading update: taking ABG to the next level
19th Oct 20237:00 amRNSThird Quarter 2023 Trading Update
22nd Aug 20237:00 amRNSAppointment of New Directors
4th Aug 202311:15 amEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) 1H’23: steering through the interest rate wave
18th Jul 20237:00 amRNSUnaudited results for the 6 months to 30 June 2023
31st May 202312:37 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
24th May 20233:23 pmRNSAnnual General Meeting Result - 2023
24th May 20237:00 amRNSAnnual General Meeting 2023 Trading Update
5th May 20233:27 pmRNSHolding(s) in Company
5th May 20238:05 amRNSDirector/PDMR Shareholding
4th May 202311:32 amRNSResult of General Meeting and Total Voting Rights
3rd May 20231:45 pmEQSHardman & Co Q&A on Arbuthnot Banking Group (ARBB): Core and new franchises growth in profits and loans
14th Apr 20235:30 pmRNSPlacing and Subscription raising £12.0 million
6th Apr 202312:15 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) 2022: profits and growth in core and new franchises
30th Mar 20237:00 amRNSAudited Final Results for the year to 31 Dec 2022
23rd Feb 20237:00 amRNSPre Close Trading Update
16th Jan 202311:25 amRNSHolding(s) in Company
6th Jan 20232:52 pmRNSHolding(s) in Company
3rd Nov 202211:00 amEQSHardman & Co - Q&A on Arbuthnot Banking Group (ARBB): More upgrades from latest trading statement
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
13th Oct 20222:42 pmRNSSale of long leasehold property
12th Oct 202212:40 pmEQSHardman & Co Research: Arbuthnot Banking Group (ARBB): 3Q’22 trading statement – yet another upgrade
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSThird Quarter 2022 Trading Update
16th Aug 20229:14 amEQSHardman & Co: Q&A on Arbuthnot Banking Group Plc (ARBB): Relationship banking benefits when interest rates rise
11th Aug 20221:50 pmEQSHardman & Co Research : Pantheon International Plc (PIN): FY’22 results: it is not just lionesses that roar
1st Aug 20227:00 amRNSDirectorate Changes
22nd Jul 202210:50 amEQSHardman & Co Research : Arbuthnot Banking Group (ARBB): The power ranger of relationship deposit banking
20th Jul 20225:19 pmRNSSale of long leasehold property
19th Jul 20227:00 amRNSHalf-year Report
6th Jul 20221:46 pmRNSChange to Sole Corporate Broker
25th May 20223:11 pmRNSResult of AGM
25th May 20221:13 pmRNSAnnual General Meeting 2022 and Trading Update
7th Apr 20223:50 pmEQSHardman & Co Research: Arbuthnot Banking Group (ARBB): Back to profitable growth with interest-rate kicker
24th Mar 20227:00 amRNSFinal Results
22nd Mar 202211:18 amRNSHolding(s) in Company
22nd Mar 20227:00 amRNSHolding in Company
16th Mar 20225:18 pmRNSHolding(s) in Company
16th Feb 20227:00 amRNSPre Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.